Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Functional and pharmacological analysis of cardiomyocytes differentiated from human peripheral blood mononuclear-derived pluripotent stem cells.

Riedel M, Jou CJ, Lai S, Lux RL, Moreno AP, Spitzer KW, Christians E, Tristani-Firouzi M, Benjamin IJ.

Stem Cell Reports. 2014 May 29;3(1):131-41. doi: 10.1016/j.stemcr.2014.04.017. eCollection 2014 Jul 8.

2.

Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells.

Sanchez-Freire V, Lee AS, Hu S, Abilez OJ, Liang P, Lan F, Huber BC, Ong SG, Hong WX, Huang M, Wu JC.

J Am Coll Cardiol. 2014 Aug 5;64(5):436-48. doi: 10.1016/j.jacc.2014.04.056.

3.

Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.

Ohmine S, Dietz AB, Deeds MC, Hartjes KA, Miller DR, Thatava T, Sakuma T, Kudva YC, Ikeda Y.

Stem Cell Res Ther. 2011 Nov 16;2(6):46. doi: 10.1186/scrt87.

4.

Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure.

Gherghiceanu M, Barad L, Novak A, Reiter I, Itskovitz-Eldor J, Binah O, Popescu LM.

J Cell Mol Med. 2011 Nov;15(11):2539-51. doi: 10.1111/j.1582-4934.2011.01417.x.

5.

Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.

Zwi-Dantsis L, Huber I, Habib M, Winterstern A, Gepstein A, Arbel G, Gepstein L.

Eur Heart J. 2013 Jun;34(21):1575-86. doi: 10.1093/eurheartj/ehs096. Epub 2012 May 22.

6.

An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes.

Jiang Y, Habibollah S, Tilgner K, Collin J, Barta T, Al-Aama JY, Tesarov L, Hussain R, Trafford AW, Kirkwood G, Sernagor E, Eleftheriou CG, Przyborski S, Stojković M, Lako M, Keavney B, Armstrong L.

Stem Cells Transl Med. 2014 Apr;3(4):416-23. doi: 10.5966/sctm.2013-0105. Epub 2014 Mar 3.

7.

A near-infrared fluorescent voltage-sensitive dye allows for moderate-throughput electrophysiological analyses of human induced pluripotent stem cell-derived cardiomyocytes.

Lopez-Izquierdo A, Warren M, Riedel M, Cho S, Lai S, Lux RL, Spitzer KW, Benjamin IJ, Tristani-Firouzi M, Jou CJ.

Am J Physiol Heart Circ Physiol. 2014 Nov 1;307(9):H1370-7. doi: 10.1152/ajpheart.00344.2014. Epub 2014 Aug 29.

8.

Effective cardiac myocyte differentiation of human induced pluripotent stem cells requires VEGF.

Ye L, Zhang S, Greder L, Dutton J, Keirstead SA, Lepley M, Zhang L, Kaufman D, Zhang J.

PLoS One. 2013;8(1):e53764. doi: 10.1371/journal.pone.0053764. Epub 2013 Jan 10.

9.

Dynamic link between histone H3 acetylation and an increase in the functional characteristics of human ESC/iPSC-derived cardiomyocytes.

Otsuji TG, Kurose Y, Suemori H, Tada M, Nakatsuji N.

PLoS One. 2012;7(9):e45010. doi: 10.1371/journal.pone.0045010. Epub 2012 Sep 12.

10.

Generation and characterization of functional cardiomyocytes derived from human T cell-derived induced pluripotent stem cells.

Seki T, Yuasa S, Kusumoto D, Kunitomi A, Saito Y, Tohyama S, Yae K, Kishino Y, Okada M, Hashimoto H, Takei M, Egashira T, Kodaira M, Kuroda Y, Tanaka A, Okata S, Suzuki T, Murata M, Fujita J, Fukuda K.

PLoS One. 2014 Jan 21;9(1):e85645. doi: 10.1371/journal.pone.0085645. eCollection 2014.

11.

Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays.

Harris K, Aylott M, Cui Y, Louttit JB, McMahon NC, Sridhar A.

Toxicol Sci. 2013 Aug;134(2):412-26. doi: 10.1093/toxsci/kft113. Epub 2013 May 20.

12.

Electronic "expression" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells.

Bett GC, Kaplan AD, Lis A, Cimato TR, Tzanakakis ES, Zhou Q, Morales MJ, Rasmusson RL.

Heart Rhythm. 2013 Dec;10(12):1903-10. doi: 10.1016/j.hrthm.2013.09.061. Epub 2013 Sep 19.

13.

Label-free electrophysiological cytometry for stem cell-derived cardiomyocyte clusters.

Myers FB, Zarins CK, Abilez OJ, Lee LP.

Lab Chip. 2013 Jan 21;13(2):220-8. doi: 10.1039/c2lc40905d. Epub 2012 Dec 3.

14.

Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes.

Chun YW, Balikov DA, Feaster TK, Williams CH, Sheng CC, Lee JB, Boire TC, Neely MD, Bellan LM, Ess KC, Bowman AB, Sung HJ, Hong CC.

Biomaterials. 2015 Oct;67:52-64. doi: 10.1016/j.biomaterials.2015.07.004. Epub 2015 Jul 14.

PMID:
26204225
15.

Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells.

Siu CW, Lee YK, Ho JC, Lai WH, Chan YC, Ng KM, Wong LY, Au KW, Lau YM, Zhang J, Lay KW, Colman A, Tse HF.

Aging (Albany NY). 2012 Nov;4(11):803-822.

16.

The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells.

Rao C, Prodromakis T, Kolker L, Chaudhry UA, Trantidou T, Sridhar A, Weekes C, Camelliti P, Harding SE, Darzi A, Yacoub MH, Athanasiou T, Terracciano CM.

Biomaterials. 2013 Mar;34(10):2399-411. doi: 10.1016/j.biomaterials.2012.11.055. Epub 2012 Dec 20.

17.

Disease characterization using LQTS-specific induced pluripotent stem cells.

Egashira T, Yuasa S, Suzuki T, Aizawa Y, Yamakawa H, Matsuhashi T, Ohno Y, Tohyama S, Okata S, Seki T, Kuroda Y, Yae K, Hashimoto H, Tanaka T, Hattori F, Sato T, Miyoshi S, Takatsuki S, Murata M, Kurokawa J, Furukawa T, Makita N, Aiba T, Shimizu W, Horie M, Kamiya K, Kodama I, Ogawa S, Fukuda K.

Cardiovasc Res. 2012 Sep 1;95(4):419-29. doi: 10.1093/cvr/cvs206. Epub 2012 Jun 27.

18.

Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells.

Mehta A, Chung YY, Ng A, Iskandar F, Atan S, Wei H, Dusting G, Sun W, Wong P, Shim W.

Cardiovasc Res. 2011 Sep 1;91(4):577-86. doi: 10.1093/cvr/cvr132. Epub 2011 May 12.

19.

Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell-derived cardiac myocyte monolayers.

Lee P, Klos M, Bollensdorff C, Hou L, Ewart P, Kamp TJ, Zhang J, Bizy A, Guerrero-Serna G, Kohl P, Jalife J, Herron TJ.

Circ Res. 2012 Jun 8;110(12):1556-63. doi: 10.1161/CIRCRESAHA.111.262535. Epub 2012 May 8.

20.

Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells.

Cao N, Liu Z, Chen Z, Wang J, Chen T, Zhao X, Ma Y, Qin L, Kang J, Wei B, Wang L, Jin Y, Yang HT.

Cell Res. 2012 Jan;22(1):219-36. doi: 10.1038/cr.2011.195. Epub 2011 Dec 6.

Items per page

Supplemental Content

Write to the Help Desk